Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Tramadol prescribed at discharge is associated with lower odds of chronic opioid use after elective total joint arthroplasty.

< BACK TO ARCHIVE


2022 Jun 27


Reg Anesth Pain Med


http://www.ncbi.nlm.nih.gov/pubmed/35760515?dopt=Abstract

Tramadol prescribed at discharge is associated with lower odds of chronic opioid use after elective total joint arthroplasty.

Authors

Tramadol prescribed at discharge is associated with lower odds of chronic opioid use after elective total joint arthroplasty.
Kiani S, Poeran J, Zhong H, Wilson LA, Poultsides L, Liu J, Memtsoudis SG
Reg Anesth Pain Med. 2022 Jun 27.
PMID: 35760515.

Abstract

We aimed to study the association between tramadol prescribed at discharge (after elective total hip and knee arthroplasty (THA/TKA) surgery) and chronic opioid use postoperatively.
Read This Paper